𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of azathioprine in Crohn’s disease during pregnancy and in the post-operative setting: a worldwide survey of experts

✍ Scribed by L. Peyrin-Biroulet; A. Oussalah; X. Roblin; M. P. Sparrow

Book ID
108606199
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
131 KB
Volume
33
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of thiopurine testing in the managem
Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: A worldwide survey of experts
✍ Xavier Roblin; Abderrahim Oussalah; Jean-Baptiste Chevaux; Miles Sparrow; Lauren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB 👁 2 views

## Background: We performed a worldwide survey to evaluate the extent to which gastroenterologists who are experts in the field of inflammatory bowel diseases (IBDs) are utilizing thiopurine metabolism in practice. Methods: This was a Web-based cross-sectional survey consisting of 12 multiple-cho

5-Aminosalicylic acid (mesalazine) use i
5-Aminosalicylic acid (mesalazine) use in Crohn's disease: A survey of the opinions and practice of Australian gastroenterologists
✍ Richard B. Gearry; Yousef Ajlouni; Sanjay Nandurkar; John H. Iser; Peter R. Gibs 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

## Background: The use of 5-aminosalicylate (5-ASA) drugs in Crohn's disease (CD) is controversial, with their continuing apparent widespread use despite high-level evidence indicating marginal benefit at best and international guidelines recommending limited indications. ## Methods: In order to

Hydroxyurea use during pregnancy: A case
Hydroxyurea use during pregnancy: A case report in sickle cell disease and review of the literature
✍ Diav-Citrin, Orna; Hunnisett, Laura; Sher, Graham D.; Koren, Gideon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 19 KB 👁 2 views

A patient being treated for sickle cell disease with hydroxyurea (1 g/d) conceived, and drug treatment was discontinued at nine weeks gestational age. The pregnancy and delivery were complicated by vaso-oclusive crises. A healthy male infant was born at 39 weeks with no evidence of congenital malfor